Aoxing Pharmaceutical Company and Phoenix PharmaLabs, Inc. Announce Strategic Alliance to Co-Develop a Novel Class of …
Student designs poster to educate people about prescription drug abuse
A Grayling High School Senior lent her talents to a task force focused on stopping the spread of prescription drug abuse. Kelsey Neuberger designed a poster for the Crawford Partnership for Substance Abuse Awareness, which says, “This Sharing is Not Caring: Stop Prescription Drug Abuse.”
Read more on Crawford County Avalanche
Tobacco Tax Hike Curbs Smoking Among Those with Mental Disorders
A new study suggests that increasing cigarette taxes could be an effective way to reduce smoking among individuals with alcohol, drug or mental disorders. The study, published online in the American Journal of Public Health, found that a 10 percent increase in cigarette pricing resulted in an 18.2 percent decline in smoking among people in these groups.
Read more on Newswise
Aoxing Pharmaceutical Company and Phoenix PharmaLabs, Inc. Announce Strategic Alliance to Co-Develop a Novel Class of …
NEW YORK, NY and SALT LAKE CITY, UT–(Marketwire – 06/03/10) – Aoxing Pharmaceutical Company, Inc. (AMEX: AXN – News ) (“Aoxing Pharma”) and Phoenix PharmaLabs, Inc. (“PPL”) today jointly announced that the companies have entered into a co-development, manufacturing and license agreement related to a novel class of poly-receptor active opioid-like drug candidates targeting pain and substance …
Read more on Marketwire via Yahoo! Finance